Home Categories API Bicalutamide
A1315512

Bicalutamide , ≥98%(HPLC),powder , 90357-06-5

Synonym(s):
Bicalutamide (CDX);Casodex;Cosudex;N-[4-Cyano-3-(trifluoromethyl)phenyl]-3-[(4-fluorophenyl)sulfonyl]-2-hydroxy-2-methylpropanamide

CAS NO.:90357-06-5

Empirical Formula: C18H14F4N2O4S

Molecular Weight: 430.37

MDL number: MFCD00869971

EINECS: 200-001-8

Pack Size Price Stock Quantity
10MG RMB23.20 In Stock
50MG RMB35.20 In Stock
200mg RMB56.00 In Stock
1G RMB82.40 In Stock
5G RMB272.80 In Stock
25g RMB1183.20 In Stock
100g RMB3879.20 In Stock
others     Enquire
Update time: 2022-07-08

PRODUCT Properties

Melting point: 191-193°C
Boiling point: 650.3±55.0 °C(Predicted)
Density  1.52±0.1 g/cm3(Predicted)
storage temp.  2-8°C
solubility  DMSO: >5mg/mL
pka 11.49±0.29(Predicted)
form  powder
color  White to Off-White
λmax 270nm(CH3CN)(lit.)
Merck  14,1200
InChI InChI=1S/C18H14F4N2O4S/c1-17(26,10-29(27,28)14-6-3-12(19)4-7-14)16(25)24-13-5-2-11(9-23)15(8-13)18(20,21)22/h2-8,26H,10H2,1H3,(H,24,25)
InChIKey LKJPYSCBVHEWIU-UHFFFAOYSA-N
SMILES C(NC1=CC=C(C#N)C(C(F)(F)F)=C1)(=O)C(O)(C)CS(C1=CC=C(F)C=C1)(=O)=O
CAS DataBase Reference 90357-06-5(CAS DataBase Reference)

Description and Uses

Bicalutamide was launched in the United Kingdom, its first worldwide market, for the treatment of advanced prostate cancer in combination with an LHRH analog or surgical castration. A non-steroidal, peripherally selective antiandrogen, bicalutamide inhibits the action of dihydrotestosterone and testosterone at target sites by competitive binding to the cytosolic androgen receptor. It was reportedly well tolerated with no significant cardiovascular and metabolic side effects due to the benefit of lacking any steroid activity. The efficacy of bicalutamide as a monotherapy has been demonstrated clinically. Promising response rates were also reported in treating colorectal, breast, pancreas and non-small cell lung cancers.

These Secondary Standards are qualified as Certified Reference Materials. These are suitable for use in several analytical applications including but not limited to pharma release testing, pharma method development for qualitative and quantitative analyses, food and beverage quality control testing, and other calibration requirements.

Safety

Symbol(GHS) 
GHS08,GHS09
Signal word  Danger
Hazard statements  H351-H360FD-H410
Precautionary statements  P202-P273-P280-P308+P313-P391-P405
Hazard Codes  Xi
Risk Statements  36/37/38
Safety Statements  26-36-24/25
RIDADR  3077
WGK Germany  3
RTECS  TX1413500
HazardClass  9
PackingGroup  III
HS Code  29242995
Hazardous Substances Data 90357-06-5(Hazardous Substances Data)

RELATED PRODUCTS